Vanguard Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1M | Buy |
|
|||||
|
2025
Q1 | $28.2M | Sell |
|
|||||
|
2024
Q4 | $24.4M | Buy |
|
|||||
|
2024
Q3 | $57M | Buy |
|
|||||
|
2024
Q2 | $35.7M | Buy |
|
|||||
|
2024
Q1 | $30.5M | Sell |
|
|||||
|
2023
Q4 | $29.6M | Sell |
|
|||||
|
2023
Q3 | $30.6M | Sell |
|
|||||
|
2023
Q2 | $36.1M | Sell |
|
|||||
|
2023
Q1 | $39.6M | Buy |
|
|||||
|
2022
Q4 | $55.1M | Buy |
|
|||||
|
2022
Q3 | $44.5M | Buy |
|
|||||
|
2022
Q2 | $35.1M | Sell |
|
|||||
|
2022
Q1 | $45.2M | Sell |
|
|||||
|
2021
Q4 | $64M | Buy |
|
|||||
|
2021
Q3 | $49.6M | Sell |
|
|||||
|
2021
Q2 | $48.9M | Sell |
|
|||||
|
2021
Q1 | $50.1M | Buy |
|
|||||
|
2020
Q4 | $47.7M | Buy |
|
|||||
|
2020
Q3 | $30.4M | Sell |
|
|||||
|
2020
Q2 | $50.4M | Sell |
|
|||||
|
2020
Q1 | $33.2M | Buy |
|
|||||
|
2019
Q4 | $35.7M | Sell |
|
|||||
|
2019
Q3 | $77.4M | Buy |
|
|||||
|
2019
Q2 | $112M | Buy |
|
|||||
|
2019
Q1 | $140M | Buy |
|
|||||
|
2018
Q4 | $121M | Buy |
|
|||||
|
2018
Q3 | $185M | Buy |
|
|||||
|
2018
Q2 | $110M | Buy |
|
|||||
|
2018
Q1 | $131M | Buy |
|
|||||
|
2017
Q4 | $91.7M | Buy |
|
|||||
|
2017
Q3 | $14.9M | Buy |
|
|||||
|
2017
Q2 | $4.93M | Buy |
|
|||||
|
2017
Q1 | $4.67M | Buy |
|